Scholars Central

Conference abstractPublished 4 Jul 2019

Good reporting practices

Authors: Samiksha Gupta

Educe Solutions, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The process of informing adverse drug reaction to the regulatory authorities or too concerned persons is known as reporting. It is mandated by drug regulatory authorities for a marketing authorization holder to report adverse event reports. Different countries have their reporting rules. The case reports should include information on adverse event, suspected and concomitant product therapy details, patient details, clinical course and outcomes, narrative, dechallenge and rechallenge information, company comments etc. The events should be coded with the most recent version of MedDRA used at the lowest level term (LLT) and in line with the latest points to consider document. The follow up information received after the submission of initial version of the case should also be reported to the regulatory authorities depending upon medical significance of the information received. Significant follow up would require reporting to the authority whereas non-significant follow up information would not. Care should be taken for the multiple cases reported in a single report e.g., multiple cases available in a single publication, mother baby case report. These reports should be linked. Upon completion of data entry in a case report, the case can be either reported as a paper format (CIOMS-I) or electronically (E2B). Case series should be developed and evaluated by the MAHs for any signal or safety information. Different parameters to considered for case evaluation are Temporal relationship, causality assessment, other confounding factors etc. On the basis of evaluation, a safety issue should be communicated to the regulatory authority as well as general public.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Formulation Science & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Formulation Science & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Samiksha Gupta”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels